iBio IBIO
NASDAQ IBIO
$1.49 +0.02 (+1.37%)
As of: Aug 21, 2026 · 11:15 AM EDT

iBio (IBIO) Net Margin (QoQ) (2011 - 2025)

iBio (IBIO) Net Margin (QoQ) (2011 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.99 Bn 132.14 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.80 Bn 78.80 Bn 3.93 Bn
3 Argenx Se 65.38 Bn 60.19 Bn 1.37 Bn
4 Moderna 60.70 Bn 55.56 Bn 52.00 Mn
5 BeOne Medicines 42.22 Bn 37.12 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.67 Bn 28.36 Bn 992.69 Mn
7 BioNTech SE 28.45 Bn 10.06 Bn 668.28 Mn
8 Insmed 27.47 Bn 26.31 Bn 358.27 Mn
9 Royalty Pharma 27.21 Bn 26.37 Bn -
10 iBio 178.20 Mn 178.20 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -325,100.00
Sep 30, 2021 -626,515.00
Jun 30, 2021 102,019.00
Mar 31, 2021 15,247.00
Dec 31, 2020 69,115.00
Sep 30, 2020 -153,172.00
Jun 30, 2020 461,685.00
Mar 31, 2020 314,649.00
Dec 31, 2019 -389,151.00
Sep 30, 2019 -361,893.00
Jun 30, 2019 23,888.00
Mar 31, 2019 -11,701.00
Dec 31, 2018 922,353.00
Sep 30, 2018 -499,363.00
Jun 30, 2018 23,516.00
Mar 31, 2018 -257,069.00
Dec 31, 2017 59,931.00
Sep 30, 2017 -20,173.00
Jun 30, 2017 765,751.00
Mar 31, 2017 -634,061.00